Cita APA

Ye, N., Jiang, N., Feng, C., Wang, F., Zhang, H., Bai, H. X., . . . Li, X. (2019). Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients. J Cancer.

Citación estilo Chicago

Ye, Ningrong, et al. "Combined Therapy Sensitivity Index Based On a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients." J Cancer 2019.

Cita MLA

Ye, Ningrong, et al. "Combined Therapy Sensitivity Index Based On a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients." J Cancer 2019.